171 related articles for article (PubMed ID: 2760097)
1. Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis.
Zerban H; Rabes HM; Bannasch P
J Cancer Res Clin Oncol; 1989; 115(4):329-34. PubMed ID: 2760097
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.
Zerban H; Radig S; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093
[TBL] [Abstract][Full Text] [Related]
3. Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis.
Bannasch P; Enzmann H; Klimek F; Weber E; Zerban H
Toxicol Pathol; 1989; 17(4 Pt 1):617-28; discussion 629. PubMed ID: 2697940
[TBL] [Abstract][Full Text] [Related]
4. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
[TBL] [Abstract][Full Text] [Related]
5. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
[TBL] [Abstract][Full Text] [Related]
6. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.
Bannasch P; Hacker HJ; Klimek F; Mayer D
Adv Enzyme Regul; 1984; 22():97-121. PubMed ID: 6591771
[TBL] [Abstract][Full Text] [Related]
8. Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine.
Klimek F; Bannasch P
Carcinogenesis; 1990 Aug; 11(8):1377-80. PubMed ID: 2387024
[TBL] [Abstract][Full Text] [Related]
9. Biochemical microanalysis of alpha-glucosidase activity in preneoplastic and neoplastic hepatic lesions induced in rats by N-nitrosomorpholine.
Klimek F; Bannasch P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(4):245-50. PubMed ID: 2569785
[TBL] [Abstract][Full Text] [Related]
10. Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
Grobholz R; Hacker HJ; Thorens B; Bannasch P
Cancer Res; 1993 Sep; 53(18):4204-11. PubMed ID: 8364915
[TBL] [Abstract][Full Text] [Related]
11. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1235-42. PubMed ID: 8020161
[TBL] [Abstract][Full Text] [Related]
12. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S; Pugh TD; Koen H; He YZ
Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
[TBL] [Abstract][Full Text] [Related]
13. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis.
Enzmann H; Bannasch P
Carcinogenesis; 1987 Nov; 8(11):1607-12. PubMed ID: 3664953
[TBL] [Abstract][Full Text] [Related]
14. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks.
Bannasch P; Khoshkhou NI; Hacker HJ; Radaeva S; Mrozek M; Zillmann U; Kopp-Schneider A; Haberkorn U; Elgas M; Tolle T
Cancer Res; 1995 Aug; 55(15):3318-30. PubMed ID: 7614467
[TBL] [Abstract][Full Text] [Related]
15. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.
Nehrbass D; Klimek F; Bannasch P
Am J Pathol; 1998 Feb; 152(2):341-5. PubMed ID: 9466558
[TBL] [Abstract][Full Text] [Related]
17. Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.
Christensen JG; Romach EH; Healy LN; Gonzales AJ; Anderson SP; Malarkey DE; Corton JC; Fox TR; Cattley RC; Goldsworthy TL
Carcinogenesis; 1999 Aug; 20(8):1583-90. PubMed ID: 10426811
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
Moore MA; Hacker HJ; Kunz HW; Bannasch P
Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
[TBL] [Abstract][Full Text] [Related]
19. Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis.
Ribback S; Calvisi DF; Cigliano A; Sailer V; Peters M; Rausch J; Heidecke CD; Birth M; Dombrowski F
J Hepatol; 2013 Jun; 58(6):1147-56. PubMed ID: 23348238
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus.
Toshkov I; Hacker HJ; Roggendorf M; Bannasch P
J Cancer Res Clin Oncol; 1990; 116(6):581-90. PubMed ID: 2152341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
